21685542|rna interference|C1136031|start=0|end=16|PHYS
21685542|potential|C3245505|start=25|end=34|CONC
21685542|applications|C0185125|start=35|end=47|PROC
21685542|chronic|C1547296^C0205191^C1555457|start=51|end=58|CONC
21685542|hbv|C0019163|start=59|end=62|DISO
21685542|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=63|end=72|PROC^CONC
21685542|phase|C0205390|start=87|end=92|CONC
21685542|safety|C0036043^C1705187|start=95|end=101|PROC^PHEN
21685542|tolerability study|C3274448|start=106|end=124|PROC
21685542|background|C1706907|start=126|end=136|CONC
21685542|rna interference|C1136031|start=138|end=154|PHYS
21685542|rnai|C1136031|start=156|end=160|PHYS
21685542|provides|C0359589|start=162|end=170|OBJC
21685542|attractive|C2346874|start=174|end=184|CONC
21685542|tool|C2827396^C0336791|start=185|end=189|OBJC
21685542|modulate|C0443264|start=193|end=201|CONC
21685542|biological|C3272559^C0005532^C1551397^C0205460^C1548762|start=202|end=212|OCCU^CONC
21685542|treat|C1292734^C1522326^C0087111|start=241|end=246|PROC^CONC
21685542|diseases|C0012634|start=253|end=261|DISO
21685542|early|C1279919|start=275|end=280|CONC
21685542|phase|C0205390|start=296|end=301|CONC
21685542|safety|C0036043^C1705187|start=321|end=327|PROC^PHEN
21685542|tolerability study|C3274448|start=332|end=350|PROC
21685542|rnai|C1136031|start=357|end=361|PHYS
21685542|based|C1705938^C1527178|start=362|end=367|CONC
21685542|therapy|C0039798^C0087111|start=368|end=375|PROC^CONC
21685542|nuc|C1417874|start=377|end=380|GENE
21685542|mild to moderate|C1299392|start=408|end=424|CONC
21685542|chronic|C1547296^C0205191^C1555457|start=425|end=432|CONC
21685542|hbv|C0019163|start=433|end=436|DISO
21685542|methods|C0025664^C0449851^C0025663|start=438|end=445|CONC
21685542|received|C1514756|start=462|end=470|CONC
21685542|single|C0205171|start=473|end=479|CONC
21685542|dose|C0869039^C0178602|start=489|end=493|CONC
21685542|nuc|C1417874|start=497|end=500|GENE
21685542|part of|C1292711|start=510|end=517|CONC
21685542|planned dose|C2826283|start=520|end=532|PROC
21685542|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=544|end=549|PROC^OBJC^CONC
21685542|reported|C0684224^C0700287|start=577|end=585|PROC^CONC
21685542|pharyngitis|C0031350|start=586|end=597|DISO
21685542|chills|C0085593|start=599|end=605|DISO
21685542|myalgia|C0231528|start=607|end=614|DISO
21685542|approximately|C0332232|start=625|end=638|CONC
21685542|single|C0205171|start=698|end=704|CONC
21685542|dose|C0869039^C0178602|start=717|end=721|CONC
21685542|symptom|C1457887|start=730|end=737|DISO
21685542|recurrences|C0034897^C2825055|start=738|end=749|DISO^PHEN
21685542|measurements|C0242485|start=751|end=763|CONC
21685542|ifn|C1415900|start=779|end=782|GENE
21685542|alpha|C0439095^C2003941^C2350010|start=784|end=789|CONC
21685542|gamma|C1552644^C1823153^C0017011^C2349976|start=795|end=800|GENE^PHEN^CONC
21685542|tumour necrosis|C0333516|start=843|end=858|DISO
21685542|factor|C1521761^C2827422|start=859|end=865|CONC
21685542|alpha|C0439095^C2003941^C2350010|start=866|end=871|CONC
21685542|performed|C0884358|start=872|end=881|CONC
21685542|revealed|C0443289|start=906|end=914|CONC
21685542|increases|C0442805^C0205217|start=924|end=933|CONC
21685542|study drug|C0013175|start=941|end=951|PROC
21685542|administration|C1533734^C0001554|start=952|end=966|PROC^ACTI
21685542|drug administration|C3469597^C0150270|start=974|end=993|PROC
21685542|ifn|C1415900|start=995|end=998|GENE
21685542|gamma|C1552644^C1823153^C0017011^C2349976|start=999|end=1004|GENE^PHEN^CONC
21685542|increased|C0442805^C0205217|start=1015|end=1024|CONC
21685542|increased|C0442805^C0205217|start=1047|end=1056|CONC
21685542|increases|C0442805^C0205217|start=1070|end=1079|CONC
21685542|returned|C3714905^C0332156|start=1080|end=1088|CONC
21685542|pretreatment|C1550147^C3539076^C3539075|start=1092|end=1104|OBJC^ACTI^CONC
21685542|levels|C0441889|start=1105|end=1111|CONC
21685542|1 week|C1442452|start=1119|end=1125|CONC
21685542|treated with|C0332293^C1522326|start=1171|end=1183|PROC^CONC
21685542|nuc|C1417874|start=1210|end=1213|GENE
21685542|subsequent|C0332282|start=1240|end=1250|CONC
21685542|antiviral therapy|C0280274|start=1251|end=1268|PROC
21685542|conclusions|C1707478|start=1270|end=1281|CONC
21685542|far|C0205108|start=1288|end=1291|CONC
21685542|nuc|C1417874|start=1293|end=1296|GENE
21685542|safety|C0036043^C1705187|start=1336|end=1342|PROC^PHEN
21685542|efficacy|C1280519^C1707887|start=1347|end=1355|PROC^CONC
21685542|studies|C0947630|start=1356|end=1363|PROC
21685542|larger|C1704243^C0549177|start=1373|end=1379|CONC
21685542|diverse|C1880371|start=1386|end=1393|CONC
21685542|patient|C1578483^C1550655^C1578480^C1578481^C1578486^C1578484^C1578485^C1578479^C1578478|start=1394|end=1401|CONC^ANAT
21685542|spectrum|C2827424^C1883073|start=1402|end=1410|CONC
21685542|increasing|C0442808|start=1417|end=1427|CONC
21685542|doses|C0178602|start=1428|end=1433|CONC
21685542|needed|C0027552^C0686904|start=1438|end=1444|CONC
21685542|appropriate|C1548787|start=1462|end=1473|CONC
21685542|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=1474|end=1478|ACTI^CONC
